Abera Bioscience AB (NGM:ABERA)
6.80
-0.02 (-0.29%)
At close: May 5, 2026
Abera Bioscience AB Market Cap
Abera Bioscience AB has a market cap or net worth of 139.39 million as of May 5, 2026. Its market cap has increased by 56.01% in one year.
Market Cap
139.39M
Enterprise Value
115.90M
Revenue
11.89M
Ranking
n/a
PE Ratio
n/a
Stock Price
6.80
Market Cap Chart
Since February 24, 2021, Abera Bioscience AB's market cap has increased from 115.59M to 139.39M, an increase of 20.60%. That is a compound annual growth rate of 3.67%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| May 5, 2026 | 139.39M | 11.12% |
| Dec 30, 2025 | 125.44M | 81.17% |
| Dec 30, 2024 | 69.24M | -7.23% |
| Dec 29, 2023 | 74.63M | 20.46% |
| Dec 30, 2022 | 61.96M | -64.21% |
| Dec 30, 2021 | 173.12M | 49.77% |
| Feb 24, 2021 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Crown Energy AB | 183.29M |
| Fable Media Group AB | 180.04M |
| EmbeddedArt Group AB | 171.57M |
| Xer Tech Holding AB | 162.89M |
| Seamless Distribution Systems AB | 161.01M |
| Prolight Diagnostics AB | 160.20M |
| Solution International Nordics AB | 158.09M |
| Eurobattery Minerals AB | 147.41M |